Tex. Health and Safety Code § 491.001
DEFINITIONS
Texas · Texas Health and Safety Code · Status: effective
Cite this
- Citation
- Tex. Health and Safety Code § 491.001, DEFINITIONS, Texas, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/674115
- Permanent ID
ys:prov:674115@1- SHA-256
fbeacae896d5e14bab47545d23888b8c9bc10844d1891d230f46c08abe4c9b33
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
In this chapter:
(1) "Individualized investigational treatment" means a drug, biological product, or device unique to and produced exclusively for use by a patient, based on the patient's genetic profile. The term includes individualized gene therapy antisense oligonucleotides and individualized neoantigen vaccines.
(2) "Life-threatening illness" means a disease or condition with:
(A) a significantly increased likelihood of death unless the course of the disease or condition is interrupted; or
(B) potentially fatal outcomes and for which the goal of clinical trials is survival.
(3) "Severely debilitating illness" means a disease or condition that causes major irreversible morbidity.